Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratoconus | 24 | 2024 | 76 | 7.350 |
Why?
|
| Visual Acuity | 35 | 2024 | 179 | 5.650 |
Why?
|
| Contact Lenses | 12 | 2024 | 71 | 3.940 |
Why?
|
| Corneal Wavefront Aberration | 14 | 2024 | 35 | 3.790 |
Why?
|
| Refractive Errors | 14 | 2013 | 58 | 2.780 |
Why?
|
| Refraction, Ocular | 16 | 2024 | 127 | 2.640 |
Why?
|
| Corneal Topography | 12 | 2024 | 37 | 2.090 |
Why?
|
| Sclera | 8 | 2021 | 57 | 1.780 |
Why?
|
| Retina | 10 | 2013 | 130 | 1.520 |
Why?
|
| Pupil | 9 | 2023 | 45 | 1.460 |
Why?
|
| Humans | 45 | 2024 | 4936 | 1.460 |
Why?
|
| Contact Lenses, Hydrophilic | 5 | 2015 | 78 | 1.430 |
Why?
|
| Cornea | 10 | 2024 | 140 | 1.210 |
Why?
|
| Adult | 27 | 2024 | 1567 | 1.150 |
Why?
|
| Vision Tests | 7 | 2022 | 50 | 0.970 |
Why?
|
| Vision, Ocular | 5 | 2020 | 34 | 0.900 |
Why?
|
| Lens, Crystalline | 5 | 2023 | 34 | 0.850 |
Why?
|
| Myopia | 3 | 2017 | 114 | 0.750 |
Why?
|
| Eyeglasses | 3 | 2023 | 30 | 0.730 |
Why?
|
| Middle Aged | 16 | 2023 | 967 | 0.700 |
Why?
|
| Aging | 3 | 2013 | 109 | 0.660 |
Why?
|
| Astigmatism | 5 | 2010 | 35 | 0.630 |
Why?
|
| Young Adult | 9 | 2024 | 787 | 0.620 |
Why?
|
| Models, Biological | 5 | 2013 | 124 | 0.600 |
Why?
|
| Female | 12 | 2024 | 2523 | 0.590 |
Why?
|
| Male | 12 | 2024 | 2491 | 0.590 |
Why?
|
| Contrast Sensitivity | 7 | 2022 | 64 | 0.530 |
Why?
|
| Visual Perception | 3 | 2013 | 57 | 0.520 |
Why?
|
| Accommodation, Ocular | 3 | 2013 | 36 | 0.490 |
Why?
|
| Vision Disorders | 3 | 2020 | 43 | 0.480 |
Why?
|
| Cataract | 2 | 2005 | 4 | 0.450 |
Why?
|
| Pattern Recognition, Visual | 1 | 2013 | 28 | 0.400 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 262 | 0.380 |
Why?
|
| Models, Theoretical | 1 | 2011 | 75 | 0.330 |
Why?
|
| Algorithms | 2 | 2013 | 241 | 0.310 |
Why?
|
| Preoperative Care | 1 | 2009 | 7 | 0.300 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2007 | 20 | 0.300 |
Why?
|
| Scattering, Radiation | 2 | 2005 | 18 | 0.290 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 37 | 0.280 |
Why?
|
| Aged | 5 | 2013 | 703 | 0.270 |
Why?
|
| Light | 2 | 2005 | 43 | 0.270 |
Why?
|
| Eye Movements | 1 | 2008 | 44 | 0.270 |
Why?
|
| Iris | 1 | 2007 | 10 | 0.260 |
Why?
|
| Rotation | 2 | 2022 | 14 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 60 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 68 | 0.240 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2006 | 3 | 0.240 |
Why?
|
| Computer Simulation | 4 | 2008 | 161 | 0.240 |
Why?
|
| Equipment Design | 3 | 2009 | 68 | 0.210 |
Why?
|
| Eye | 1 | 2022 | 20 | 0.190 |
Why?
|
| Benchmarking | 1 | 2022 | 12 | 0.180 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2021 | 4 | 0.180 |
Why?
|
| Reference Values | 2 | 2012 | 26 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 11 | 0.160 |
Why?
|
| Treatment Outcome | 2 | 2013 | 177 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 27 | 0.150 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2019 | 5 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2017 | 32 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2017 | 111 | 0.130 |
Why?
|
| Aberrometry | 2 | 2020 | 8 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 137 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2004 | 115 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2004 | 62 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2013 | 20 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2004 | 269 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 83 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 24 | 0.090 |
Why?
|
| Prosthesis Fitting | 2 | 2020 | 23 | 0.080 |
Why?
|
| Linear Models | 2 | 2011 | 58 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2009 | 11 | 0.070 |
Why?
|
| Reference Standards | 1 | 2009 | 12 | 0.070 |
Why?
|
| Vision, Monocular | 1 | 2007 | 16 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2008 | 136 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 97 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 126 | 0.060 |
Why?
|
| Prognosis | 1 | 2006 | 60 | 0.060 |
Why?
|
| Refractometry | 1 | 2006 | 6 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 318 | 0.060 |
Why?
|
| Time Factors | 1 | 2005 | 163 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2004 | 81 | 0.050 |
Why?
|
| Awards and Prizes | 1 | 2004 | 2 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2004 | 7 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2004 | 10 | 0.050 |
Why?
|
| Optometry | 1 | 2004 | 14 | 0.050 |
Why?
|
| Mathematics | 1 | 2003 | 27 | 0.050 |
Why?
|
| Prescriptions | 1 | 2023 | 19 | 0.050 |
Why?
|
| Texas | 1 | 2004 | 190 | 0.050 |
Why?
|
| Optics and Photonics | 1 | 2020 | 21 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 31 | 0.040 |
Why?
|
| Disease Progression | 1 | 2009 | 59 | 0.020 |
Why?
|
| Mydriatics | 1 | 2004 | 11 | 0.010 |
Why?
|